Biotech Values

[DewDiligence]

VRTX AASLD PR is instructive for implicit ordering of relevance to company of its HCV drugs:

http://finance.yahoo.com/news/vertex-announces-presentation-data-hepatitis-144600494.html

In descending order of relevance, the three drugs are: i) ALS-2200 (a/k/a VX-135), the pyrimidine nuke acquired from Alios; ii) Incivek; and iii) VX-222, the non-nuke acquired from ViroChem that doesn’t work too well.